When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. MDMA-assisted psychotherapy - Wikipedia

   en.wikipedia.org/wiki/MDMA-assisted_psychotherapy

   A phase III study indicated that MDMA-assisted therapy represents a potential breakthrough treatment for severe PTSD that merits expedited clinical evaluation. [17] Based on this study, MDMA-assisted psychotherapy was granted breakthrough therapy designation by the FDA, a designation that indicates that there is preliminary evidence that an intervention might offer a substantial improvement ...

3. List of antidepressants - Wikipedia

   en.wikipedia.org/wiki/List_of_antidepressants

   This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification.

4. Tinnitus retraining therapy - Wikipedia

   en.wikipedia.org/wiki/Tinnitus_retraining_therapy

   pharmacological – No drug has been approved by the U.S. Food and Drug Administration (FDA) for treating tinnitus. However, various pharmacological treatments, including antidepressants, anxiolytics, vasodilators and vasoactive substances, and intravenous lidocaine have been prescribed for tinnitus [21]

5. FDA approves first fast-acting oral drug for clinical depression

   www.aol.com/fda-approves-first-fast-acting...

   For premium support please call: 800-290-4726 more ways to reach us

6. FDA approves Johnson & Johnson’s ketamine-derived ... - AOL

   www.aol.com/finance/fda-approves-johnson-johnson...

   The nasal spray was first approved by the FDA in 2019 as a supplemental treatment, along with an oral medication, for the approximately one-third of people with MDD who struggle with treatment ...

7. Rejoyn - Wikipedia

   en.wikipedia.org/wiki/Rejoyn

   Rejoyn is a prescription-only digital therapeutic smartphone app approved by the US FDA for the treatment of major depressive disorder (MDD) in adults ages 22 and up. [1] It is prescribed in conjunction with standard antidepressant medication and professional guidance and support.